Approval expands SIMPONI® indication to treat children weighing at least 15 kg with moderately to severely active ulcerative colitis SIMPONI® is the only approved treatment to offer a monthly maintenance dose for… Read More
DUBLIN – Aon plc, a leading global professional services firm, forecasts that medical plan costs worldwide will rise by an average of 9.8 percent in 2026, according to its 2026… Read More
SAN FRANCISCO and VANCOUVER, BC — Jade Biosciences, Inc, a clinical-stage biotechnology company focused on developing best-in-class therapies for autoimmune diseases, announced that it has entered into a securities purchase… Read More
UBC Faculty of Medicine researchers have received more than $4.3 million from the Government of Canada to address barriers to abortion access for underserved populations The funding, awarded through Canada’s… Read More
An implantable, rapid alert system streamlines tissue flap monitoring, enabling quick action to save surgical flaps and avert additional surgeries. A new implantable tissue monitoring technology could be a gamechanger… Read More
